The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial
暂无分享,去创建一个
K. Shen | Xiaosong Chen | Li Zhu | Jiayi Wu | Deyue Liu | Caijin Lin | S. Ding | O. Huang | Jianrong He | Wei-guo Chen | Yan Fang | Jin Hong | Jiahui Huang | W. Gao | Siji Zhu | Ya-fei Li | Shuangshuang Lu | Xiao-song Chen | Cai-Jin Lin